⚠️ High Alert Medication

Dobutamine Infusion

Syringe pump continuous infusion preparation (5,000 mcg/mL), inotropic titration, and hemodynamic surveillance protocol.

Syringe Pump Infusion Preparation (Standard Concentration)

Ampoule Presentation 250 mg per 5 mL ampoule
Dobutamine Dose 250 mg (5 mL = one 5 mL ampoule)
Compatible Diluent 45 mL of D5W or 0.9% Sodium Chloride (NS)
Final Syringe Volume 50 mL
Final Concentration 5,000 mcg/mL (5 mg/mL)
Stability 24 hours at room temperature

Materials Required

  • Dobutamine ampoule 250 mg/5 mL × 1
  • 60 mL Luer-lock syringe
  • 0.9% Sodium Chloride (NS) or 5% Dextrose (D5W)
  • Sterile drawing-up needle / filter needle
  • Dedicated syringe pump infusion label
  • Extension line (100 cm)
  • Alcohol chlorhexidine swabs

Preparation Procedure (Aseptic Non-Touch Technique)

  1. Verification: Verify the written physician order, patient identity, body weight, and clinical indication.
  2. Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
  3. Ampoule Check: Check the dobutamine ampoule for:
    • Correct drug and strength, dobutamine hydrochloride (50 mg/mL)
    • Expiry date
    • Container integrity, clarity, and absence of precipitate
  4. Withdrawal: Open one ampoule of dobutamine. Withdraw 5 mL into a 60 mL Luer-lock syringe (Total dobutamine drawn: 5 mL = 250 mg dobutamine).
  5. Dilution: Add 45 mL of 0.9% Sodium Chloride or D5W to a final volume of 50 mL.
  6. Mixing: Gently invert the syringe several times to ensure uniform mixing.
  7. Visual Inspection: Inspect solution to ensure it is clear and free of visible particles. A faint pink tint may develop from mild oxidation without significant loss of potency; discard if cloudy, precipitated, or markedly discoloured.
  8. Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
  9. Syringe Pump Setup: Prime the extension set and install into the syringe pump.

🔒 Lumen Policy: Dobutamine is inactivated in alkaline solutions (sodium bicarbonate) and is incompatible with numerous medications, including heparin, furosemide, and aminophylline. Infuse via a dedicated lumen, preferably central.

⚠️ Peripheral Administration: Dobutamine may be infused through a large, well-secured peripheral vein when central access is unavailable, with regular site checks for infiltration.

Administration & Titration

Recommended Dosing Parameters

  • Administration Route: Administer via syringe pump; dedicated lumen preferred.
  • Recommended Starting Dose: 2.5 mcg/kg/min (titrate infusion to achieve desired hemodynamic result).
  • Titration Step: Increase by 2.5 mcg/kg/min every 10 to 30 minutes according to response.
  • Typical ICU Titration Range: 2.5 to 10 mcg/kg/min.
  • Maximum Dose: 20 mcg/kg/min. Higher doses only under direct intensivist supervision.
  • Hypovolemia: Correct intravascular volume depletion before initiation.
  • Weaning: Reduce gradually while monitoring cardiac output and perfusion markers.
  • Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
  • Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes cloudy, precipitated, or contaminated.

Hemodynamic Monitoring Requirements

  • Monitor arterial blood pressure continuously (invasive arterial line preferred).
  • Monitor heart rate and continuous ECG rhythm for sinus tachycardia, atrial fibrillation, and ventricular ectopy.
  • Observe for chest pain or ECG changes suggesting myocardial ischemia.
  • Track cardiac output indices where available (echocardiography, ScvO2, cardiac output monitoring).
  • Assess end-organ perfusion markers (urine output, mental status, capillary refill, serum lactate).
  • Check serum potassium periodically; β-agonism can lower potassium.

Clinical Cautions

  • Atrial Fibrillation: Enhances AV conduction and can produce a rapid ventricular response.
  • β-Blockers: Blunt the inotropic response; higher doses may be required.
  • Prolonged Infusion: Tolerance may develop after about 72 hours.
  • Contraindicated: Hypertrophic obstructive cardiomyopathy (dynamic LVOT obstruction) and known hypersensitivity, including to sulfite-containing formulations.

Infusion Site Surveillance & Response Protocol

Dobutamine is a weaker vasoconstrictor than vasopressors, but extravasation can still cause local irritation, inflammation, and tissue injury.

Normal Infusion Site

  • No cutaneous blanching or erythema
  • No local swelling
  • No pain, burning, or stinging
  • No tissue discolouration

Extravasation Suspected:

  1. STOP infusion immediately (do not flush line).
  2. Notify clinician promptly and arrange alternative access so the infusion is not interrupted for long.
  3. Aspirate residual drug through the cannula if possible, then remove catheter.
  4. Document event in patient clinical record.

Dobutamine Infusion Rate Chart (5,000 mcg/mL)

Shows equivalent dose in mcg/kg/min for a given pump rate (mL/hr) across patient weights. Dedicated lumen administration preferred.

Rate
(mL/hr)
Weight (Kg) and Dose (mcg/kg/min)
40 kg 45 kg 50 kg 55 kg 60 kg 65 kg 70 kg 75 kg 80 kg 85 kg 90 kg 95 kg 100 kg
12.11.91.71.51.41.31.21.11.01.00.90.90.8
24.23.73.33.02.82.62.42.22.12.01.91.81.7
36.25.65.04.54.23.83.63.33.12.92.82.62.5
48.37.46.76.15.65.14.84.44.23.93.73.53.3
510.49.38.37.66.96.46.05.65.24.94.64.44.2
612.511.110.09.18.37.77.16.76.25.95.65.35.0
714.613.011.710.69.79.08.37.87.36.96.56.15.8
816.714.813.312.111.110.39.58.98.37.87.47.06.7
918.816.715.013.612.511.510.710.09.48.88.37.97.5
1020.818.516.715.213.912.811.911.110.49.89.38.88.3
1122.920.418.316.715.314.113.112.211.510.810.29.69.2
1225.022.220.018.216.715.414.313.312.511.811.110.510.0
1327.124.121.719.718.116.715.514.413.512.712.011.410.8
1429.225.923.321.219.417.916.715.614.613.713.012.311.7
1531.227.825.022.720.819.217.916.715.614.713.913.212.5
1633.329.626.724.222.220.519.017.816.715.714.814.013.3
1735.431.528.325.823.621.820.218.917.716.715.714.914.2
1837.533.330.027.325.023.121.420.018.817.616.715.815.0
1939.635.231.728.826.424.422.621.119.818.617.616.715.8
2041.737.033.330.327.825.623.822.220.819.618.517.516.7
2143.838.935.031.829.226.925.023.321.920.619.418.417.5
2245.840.736.733.330.628.226.224.422.921.620.419.318.3
2347.942.638.334.831.929.527.425.624.022.521.320.219.2
2450.044.440.036.433.330.828.626.725.023.522.221.120.0
Within usual range (≤ 20 mcg/kg/min) Exceeds 20 mcg/kg/min maximum

Infusion Conversion (Solution Concentration 5,000 mcg/mL)

Standard equations for a 5,000 mcg/mL solution (250 mg in 50 mL):

Infusion Rate (mL/hr):

Rate (mL/hr) = [ Dose (mcg/kg/min) × Weight (kg) × 60 ] / 5000

Shortcut: Rate = Dose × Weight × 0.012
Infusion Dose (micrograms/kg/minute):

Dose (mcg/kg/min) = [ Rate (mL/hour) × Concentration (5000 mcg/mL) ] / [ Weight (kg) × 60 ]

'Shortcut' example: 70 kg patient at 5 mcg/kg/min → 5 × 70 × 0.012 = 4.2 mL/hr.

© criticalcareinsights.com. All rights reserved. For clinical reference and educational use only.